AstraZeneca Share Holder Equity 2010-2024 | AZN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AstraZeneca share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

AstraZeneca share holder equity for the quarter ending March 31, 2024 was $37.501B, a 4.72% increase year-over-year.
AstraZeneca share holder equity for 2023 was $39.166B, a 5.69% increase from 2022.
AstraZeneca share holder equity for 2022 was $37.058B, a 5.67% decline from 2021.
AstraZeneca share holder equity for 2021 was $39.287B, a 151.23% increase from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AstraZeneca share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

AstraZeneca share holder equity for the quarter ending March 31, 2024 was $37.501B, a 4.72% increase year-over-year.
AstraZeneca share holder equity for 2023 was $39.166B, a 5.69% increase from 2022.
AstraZeneca share holder equity for 2022 was $37.058B, a 5.67% decline from 2021.
AstraZeneca share holder equity for 2021 was $39.287B, a 151.23% increase from 2020.